Oral melatonin reduces blood coagulation activity: A placebo-controlled study in healthy young men

Journal of Pineal Research

Volumn 44, Issue 2, 2008, Pages 127-133

  Wirtz, Petra H ^a   Spillmann, Maria ^a   Bärtschi, Carmen ^a   Ehlert, Ulrike ^a   Von Känel, Roland ^b,c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cardiovascular disease; Hemostasis; Melatonin; Pineal gland; Placebo; Thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; D DIMER; FIBRINOGEN; MELATONIN; NORADRENALIN; PLACEBO;

ADULT; ARTICLE; BLOOD CLOTTING; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; NORADRENALIN BLOOD LEVEL; PROTEIN FUNCTION; REGRESSION ANALYSIS; SINGLE DRUG DOSE;

EID: 39149142497     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00499.x     Document Type: Article

References (48)

1. Tan DX, Manchester LC, Hardeland R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003 34 : 75 78.
2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005 111 : 3481 3488.
3. Levi M, Van Der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004 109 : 2698 2704.
4. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 : 1708 1714.
5. Carrillo-Vico A, Guerrero JM, Lardone PJ et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005 27 : 189 200.
6. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005 9 : 11 24.
7. Dahm A, Osterud B, Hjeltnes N et al. Opposite circadian rhythms in melatonin and tissue factor pathway inhibitor type 1: does daylight affect coagulation? J Thromb Haemost 2006 4 : 1840 1842.
8. Brugger P, Marktl W, Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 1995 345 : 1408.
9. Sakotnik A, Liebmann PM, Stoschitzky K et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J 1999 20 : 1314 1317.
10. Yaprak M, Altun A, Vardar A et al. Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. Int J Cardiol 2003 89 : 103 107.
11. Girotti L, Lago M, Ianovsky O et al. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res 2000 29 : 138 142.
12. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia MJ et al. Decreased nocturnal melatonin levels during acute myocardial infarction. J Pineal Res 2002 33 : 248 252.
13. Dominguez-Rodriguez A, Garcia-Gonzalez M, Abreu-Gonzalez P et al. Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006 97 : 10 12.
14. Jonas M, Garfinkel D, Zisapel N et al. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 2003 12 : 19 24.
15. Scheer FA, Van Montfrans GA, Van Someren EJ et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004 43 : 192 197.
16. Lotufo CM, Lopes C, Dubocovich ML et al. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur J Pharmacol 2001 430 : 351 357.
17. Del Zar MM, Martinuzzo M, Falcon C et al. Inhibition of human platelet aggregation and thromboxane-B2 production by melatonin: evidence for a diurnal variation. J Clin Endocrinol Metab 1990 70 : 246 251.
18. Kornblihtt LI, Finocchiaro L, Molinas FC. Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid. J Pineal Res 1993 14 : 184 191.
19. Tunali T, Sener G, Yarat A et al. Melatonin reduces oxidative damage to skin and normalizes blood coagulation in a rat model of thermal injury. Life Sci 2005 76 : 1259 1265.
20. De Stavola BL, Meade TW. Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). J Thromb Haemost 2007 5 : 461 471.
21. Meade TW, Cooper JA, Stirling Y et al. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol 1994 88 : 601 607.
22. Danesh J, Lewington S, Thompson SG et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005 294 : 1799 1809.
23. Danesh J, Whincup P, Walker M et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation 2001 103 : 2323 2327.
24. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007 27 : 1687 1693.
25. Vlot AJ, Koppelman SJ, Bouma BN et al. Factor VIII and von Willebrand factor. Thromb Haemost 1998 79 : 456 465.
26. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003 89 : 601 609.
27. Lowe GD. Fibrin D-dimer and cardiovascular risk. Semin Vasc Med 2005 5 : 387 398.
28. Brzezinski A. Melatonin in humans. N Engl J Med 1997 336 : 186 195.
29. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957 17 : 237 246.
30. Ehrenreich H, Schuck J, Stender N et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997 21 : 1285 1293.
31. Vieira R, Miguez J, Lema M et al. Pineal and plasma melatonin as determined by high-performance liquid chromatography with electrochemical detection. Anal Biochem 1992 205 : 300 305.
32. Hornung R, Reed L. Estimation of average concentration in the presence of nondectable values. Appl Occup Environ Hyg 1990 5 : 46 51.
33. Finkelstein MM, Verma DK. Exposure estimation in the presence of nondetectable values: another look. AIHAJ 2001 62 : 195 198.
34. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004 66 : 411 421.
35. Kannel WB, Wolf PA, Castelli WP et al. Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987 258 : 1183 1186.
36. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984 311 : 501 505.
37. Colman RW, Hirsh J, Marder VJ et al. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Lippincott Williams & Wilkins, Philadelphia, 2001. pp. 3 16.
38. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 1998 25 : 184 191.
39. Von Kanel R, Dimsdale JE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000 65 : 357 369.
40. Von Kanel R, Mills PJ, Ziegler MG et al. Effect of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002 144 : 68 72.
41. Wirtz PH, Ehlert U, Emini L et al. Anticipatory cognitive stress appraisal and the acute procoagulant stress response in men. Psychosom Med 2006 68 : 851 858.
42. K-Laflamme A, Wu L, Foucart S et al. Impaired basal sympathetic tone and alpha1-adrenergic responsiveness in association with the hypotensive effect of melatonin in spontaneously hypertensive rats. Am J Hypertens 1998 11 : 219 229.
43. Girouard H, Chulak C, Lejossec M et al. Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats. J Hypertens 2003 21 : 179 188.
44. Arangino S, Cagnacci A, Angiolucci M et al. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol 1999 83 : 1417 1419.
45. Cagnacci A, Arangino S, Angiolucci M et al. Influences of melatonin administration on the circulation of women. Am J Physiol 1998 274 : R335 R338.
46. Nishiyama K, Yasue H, Moriyama Y et al. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J 2001 141 : E9.
47. Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis. Curr Mol Med 2006 6 : 489 499.
48. Muller G, Goettsch C, Morawietz H. Oxidative stress and endothelial dysfunction. Hamostaseologie 2007 27 : 5 12.